Letter to the editor| Volume 113, ISSUE 5, P594, May 1993

Use of biphosphonates in preoperative treatment of patients with hyperparathyroidism

      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Jansson S
        • Tisell LE
        • Lindstedt G
        • Lundberg P
        Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism.
        Surgery. 1991; 110: 480-486
        • Lishman WA
        Organic psychiatry.
        in: 2nd ed. Blackwell Scientific Publications, London1987: 447-450
        • van Breukelen FJM
        • Bijvoet OLM
        • Frijlink WB
        Efficacy of aminohydroxypropylidene bisphosphonate in hypercalcaemia: observations on regulation of serum calcium.
        Calcif Tissue Int. 1982; 34: 321-327
        • Tisell LE
        • Hedback G
        • Jansson S
        • Lindstedt G
        • Zachrisson BF
        Management of hyperparathyroid patients with grave hypercalcaemia.
        World J Surg. 1991; 15: 730-737
        • Fitton A
        • McTavish D
        Pamidronate: a review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.
        Drugs. 1991; 41: 289-318